Cost-utility analysis of add-on ezetimibe to moderate-intensity statin versus moderate-intensity statin alone for secondary prevention in patients with acute coronary syndrome intolerant to high-intensity statin therapy in Thailand
{{output}}
Background: Although high-intensity statin therapy is recommended for the secondary prevention of acute coronary syndrome (ACS), a subset of patients is unable to tolerate such regimens due to statin-associated adverse effects. F... ...